98 related articles for article (PubMed ID: 8855817)
1. Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo.
Ain KB; Tofiq S; Taylor KD
J Clin Endocrinol Metab; 1996 Oct; 81(10):3650-3. PubMed ID: 8855817
[TBL] [Abstract][Full Text] [Related]
2. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells.
Yeung SC; Xu G; Pan J; Christgen M; Bamiagis A
Cancer Res; 2000 Feb; 60(3):650-6. PubMed ID: 10676649
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model.
Yeung SC; She M; Yang H; Pan J; Sun L; Chaplin D
J Clin Endocrinol Metab; 2007 Aug; 92(8):2902-9. PubMed ID: 17550961
[TBL] [Abstract][Full Text] [Related]
4. In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma.
Klopper JP; Berenz A; Hays WR; Sharma V; Pugazhenthi U; Janssen J; Singh M; Bissonnette RP; Haugen BR
Clin Cancer Res; 2008 Jan; 14(2):589-96. PubMed ID: 18223235
[TBL] [Abstract][Full Text] [Related]
5. Combretastatin A4 phosphate has primary antineoplastic activity against human anaplastic thyroid carcinoma cell lines and xenograft tumors.
Dziba JM; Marcinek R; Venkataraman G; Robinson JA; Ain KB
Thyroid; 2002 Dec; 12(12):1063-70. PubMed ID: 12593719
[TBL] [Abstract][Full Text] [Related]
6. Selective activity of BS-RNase against anaplastic thyroid cancer.
Kotchetkov R; Cinatl J; Krivtchik AA; Vogel JU; Matousek J; Pouckova P; Kornhuber B; Schwabe D; Cinatl J
Anticancer Res; 2001; 21(2A):1035-42. PubMed ID: 11396137
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.
Ain KB; Taylor KD; Tofiq S; Venkataraman G
J Clin Endocrinol Metab; 1997 Jun; 82(6):1857-62. PubMed ID: 9177396
[TBL] [Abstract][Full Text] [Related]
8. Effects of low and high concentrations of antitumour drug taxol in anaplastic thyroid cancer cells.
Pushkarev VM; Starenki DV; Saenko VA; Yamashita S; Kovzun OI; Popadiuk ID; Pushkarev VV; Tronko MD
Exp Oncol; 2009 Mar; 31(1):16-21. PubMed ID: 19300411
[TBL] [Abstract][Full Text] [Related]
9. ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines.
Portella G; Scala S; Vitagliano D; Vecchio G; Fusco A
J Clin Endocrinol Metab; 2002 Jun; 87(6):2525-31. PubMed ID: 12050209
[TBL] [Abstract][Full Text] [Related]
10. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model.
Gomez-Rivera F; Santillan-Gomez AA; Younes MN; Kim S; Fooshee D; Zhao M; Jasser SA; Myers JN
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4519-27. PubMed ID: 17671138
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma.
Xu G; Pan J; Martin C; Yeung SC
J Clin Endocrinol Metab; 2001 Apr; 86(4):1769-77. PubMed ID: 11297616
[TBL] [Abstract][Full Text] [Related]
12. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
13. Effects of Paclitaxel and combination of the drug with radiation therapy in an in vivo model of anaplastic thyroid carcinoma.
Pushkarev VM; Starenki DV; Saenko VO; Tronko MD; Yamashita S
Exp Oncol; 2011 Mar; 33(1):24-7. PubMed ID: 21423091
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of low and high doses of Taxol in anaplastic thyroid cancer cells: possible implication of the Pin1 prolyl isomerase.
Pushkarev VM; Starenki DV; Saenko VA; Pushkarev VV; Kovzun OI; Tronko MD; Popadiuk ID; Yamashita S
Exp Oncol; 2008 Sep; 30(3):190-4. PubMed ID: 18806740
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of the effects of low concentrations of taxol in anaplastic thyroid cancer cells.
Pushkarev VM; Starenki DV; Saenko VA; Namba H; Kurebayashi J; Tronko MD; Yamashita S
Endocrinology; 2004 Jul; 145(7):3143-52. PubMed ID: 15044368
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
Luong QT; O'Kelly J; Braunstein GD; Hershman JM; Koeffler HP
Clin Cancer Res; 2006 Sep; 12(18):5570-7. PubMed ID: 17000694
[TBL] [Abstract][Full Text] [Related]
17. Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinoma.
Auzenne E; Donato NJ; Li C; Leroux E; Price RE; Farquhar D; Klostergaard J
Clin Cancer Res; 2002 Feb; 8(2):573-81. PubMed ID: 11839679
[TBL] [Abstract][Full Text] [Related]
18. Concurrent cetuximab and bevacizumab therapy in a murine orthotopic model of anaplastic thyroid carcinoma.
Prichard CN; Kim S; Yazici YD; Doan DD; Jasser SA; Mandal M; Myers JN
Laryngoscope; 2007 Apr; 117(4):674-9. PubMed ID: 17429874
[TBL] [Abstract][Full Text] [Related]
19. Effects of tamoxifen and somatostatin analogue on growth of human medullary, follicular, and papillary thyroid carcinoma cell lines: tissue culture and nude mouse xenograft studies.
Weber CJ; Marvin M; Krekun S; Koschitzky T; Karp F; Benson M; Feind CR
Surgery; 1990 Dec; 108(6):1065-71. PubMed ID: 1978945
[TBL] [Abstract][Full Text] [Related]
20. Modulation of parathyroid hormone-related protein levels (PTHrP) in anaplastic thyroid cancer.
Dackiw A; Pan J; Xu G; Yeung SC
Surgery; 2005 Sep; 138(3):456-63. PubMed ID: 16213899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
